| COMbination of Bipolar Androgen Therapy and Nivolumab (NCT03554317) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-09-05 |
| Hormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate Cancer (NCT02913859) | University Hospital Sestre Milosrdnice | 2018-09-01 |
| Trial of eRapa in Prostate Cancer Patients (NCT03618355) | Rapamycin Holdings, Inc. dba Emtora Biosciences | 2018-08-28 |
| Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer Biopsy (NCT03585660) | University of Chicago | 2018-08-28 |
| RCT-evaluation of Retzius-sparing Robotic Prostatectomy (NCT03787823) | Heidelberg University | 2018-08-27 |
| MRI-guided Stereotactic Body Radiotherapy (SBRT) With Simultaneous Integrated Boost for Prostate Cancer (NCT03664193) | Weill Medical College of Cornell University | 2018-08-24 |
| Phase I/II Study of Hydroxychloroquine With Itraconazole With Biochemically Recurrent Prostate Cancer (NCT03513211) | St Vincent's Hospital, Sydney | 2018-08-23 |
| Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors (NCT03662204) | Exact Sciences Corporation | 2018-08-23 |
| Impact of Acetazolamide in Reducing Referred Postoperative Pain (NCT04470843) | Medical College of Wisconsin | 2018-08-22 |
| A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment (NCT03572387) | Icahn School of Medicine at Mount Sinai | 2018-08-20 |
| Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients. (NCT03644303) | Royal Marsden NHS Foundation Trust | 2018-08-13 |
| PSMA-based 18F-DCFPyL PET/CT: Evaluating Its Application in Real Life (NCT03609736) | Grand River Hospital | 2018-08-10 |
| Prostate Radiotherapy Integrated With Simultaneous MRI (The PRISM Study) (NCT03658525) | Royal Marsden NHS Foundation Trust | 2018-08-07 |
| Prevention of Obesity-related Cancers: Setting up of a Multi-Cancer Education and Prevention Program in Hong Kong (NCT04034953) | Chinese University of Hong Kong | 2018-08-06 |
| Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery (NCT03541928) | The Methodist Hospital Research Institute | 2018-08-02 |
| PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancer (NCT05732948) | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | 2018-08-02 |
| Comparison of a Novel Leuprolide With Market Leuprolide (NCT03662958) | Lee's Pharmaceutical Limited | 2018-08-01 |
| Nerve-sparing, Robot-assisted Radical Prostatectomy Using a Personalized, 3D-printed Prostate Model for Selective Resection of Positive Surgical Margins (NCT05960669) | University Hospital, Basel, Switzerland | 2018-08-01 |
| Prostate Cancer Biomarker Enrichment and Treatment Selection (NCT03385655) | Canadian Cancer Trials Group | 2018-08-01 |
| Active Surveillance for Low-risk Prostate Cancer - Evaluation of the Efficacy of Minimally Invasive Active Surveillance (NCT03956108) | Karolinska Institutet | 2018-08-01 |
| Clinical Application of 68Ga-PSMA PET in Prostate Cancer (NCT03650946) | National Taiwan University Hospital | 2018-08-01 |
| Effects of a Neuroscience-based Technique on Cancer Patients Announced of a Palliative Disease Progression and Partners (NCT03652298) | Centre Oscar Lambret | 2018-07-25 |
| Qudratus Lumborum Block for Postoperative Pain After Endoscopic Prostatectomy. (NCT03600129) | Centre of Postgraduate Medical Education | 2018-07-25 |
| Pioneering Advances in Care and Education (PACE) (NCT03397160) | University of California, San Francisco | 2018-07-19 |
| Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance (NCT03933670) | University of California, San Francisco | 2018-07-18 |
| Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome (NCT03031821) | Canadian Urologic Oncology Group | 2018-07-12 |
| CyberKnife Dose Escalation Prostate Cancer Trial (NCT03822494) | Crozer-Keystone Health System | 2018-07-12 |
| Study of Metformin Plus Oligomeric Procyanidin Complex for Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients (NCT03465345) | Medical University of South Carolina | 2018-07-11 |
| High-Intensity Training for Men With Prostate Cancer on Active Surveillance: A Feasibility Study (NCT04266262) | University of Toronto | 2018-07-09 |
| Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy (NCT03253744) | National Cancer Institute (NCI) | 2018-07-05 |
| A Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate Cancer (NCT03561220) | University of Florida | 2018-07-05 |
| [68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR) (NCT03724253) | Advanced Accelerator Applications | 2018-07-03 |
| Exercise During Active Surveillance for Prostate Cancer (NCT03203460) | University of Alberta | 2018-07-01 |
| Feasibility of Prostatic Arterial Embolization in Low-risk Patients With Unilateral Prostate Cancer Under Active Surveillance: Monocentric Pilot Study (NCT03407963) | Centre Hospitalier Universitaire de Nīmes | 2018-06-26 |
| Study of Dose Escalation of Abiraterone Actetate in Prostate Cancer (NCT03458247) | Assistance Publique - Hôpitaux de Paris | 2018-06-22 |
| Prostate Cancer Patient Management With 18F-DCFPyL PET/CT (NCT03459820) | Sir Mortimer B. Davis - Jewish General Hospital | 2018-06-22 |
| Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma (NCT03436654) | Memorial Sloan Kettering Cancer Center | 2018-06-21 |
| A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer (NCT03574571) | Memorial Sloan Kettering Cancer Center | 2018-06-19 |
| 68Ga-THP-PSMA PET/CT Imaging in High Risk Primary Prostate Cancer or Biochemical Recurrence of Prostate Cancer (NCT03617588) | Theragnostics Ltd | 2018-06-18 |
| PSMA PET/CT for Prostate Cancer (NCT03573011) | University Hospital, Ghent | 2018-06-15 |
| Methionine-Restricted Diet to Potentiate The Effects of Radiation Therapy (NCT03574194) | West Virginia University | 2018-06-12 |
| Cystoprostatectomy Versus Radiotherapy Combined With ADT for the Treatment of cT4 Prostate Cancer With Bladder Invasion (NCT03482089) | Tongji Hospital | 2018-06-12 |
| PET/MRI for the Staging of Newly Diagnosed Prostate Cancer (NCT03392181) | Northwestern University | 2018-06-08 |
| Therapeutics in Active Prostate Cancer Surveillance (NCT03365297) | CCTU- Cancer Theme | 2018-06-05 |
| TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer (NCT04552509) | Linda Chan, MD | 2018-06-05 |
| Nivolumab in Prostate Cancer With DNA Repair Defects (ImmunoProst Trial) (NCT03040791) | Hospital Moinhos de Vento | 2018-06-01 |
| External Validation of Prostate MRI QCAD/Lyon (NCT03687918) | Hospices Civils de Lyon | 2018-06-01 |
| MRI Guided Prostate Cancer Focal Laser Ablation (NCT03634579) | Emory University | 2018-06-01 |
| Initial Experience in Brazilian Single Center With High Intensity Focalized Ultrasound (HIFU) Prostate Cancer Therapy: Morbidity, Oncological and Functional Outcomes. (NCT03255135) | Hospital de Transplante Doutor Euryclides de Jesus Zerbini | 2018-05-31 |
| 5 Fractions of Pelvic SABR With Intra Prostatic SABR Boost: (NCT04245670) | Sunnybrook Health Sciences Centre | 2018-05-31 |
| 3D Versus Robot Assisted Laparoscopic Prostatectomy. (NCT03550040) | Tampere University Hospital | 2018-05-31 |
| A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer (NCT03520478) | Jiangsu HengRui Medicine Co., Ltd. | 2018-05-30 |
| Efficacy of a Couple-Focused mHealth Symptom Self-management Program (NCT03489057) | UNC Lineberger Comprehensive Cancer Center | 2018-05-30 |
| Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer (NCT03511664) | Endocyte | 2018-05-29 |
| BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair Genes (NCT03432897) | Brown University | 2018-05-25 |
| Effect of Anesthetic Method on Optic Nerve Sheath Diameter in Patients Undergoing RALP (NCT03529643) | Asan Medical Center | 2018-05-24 |
| Mp-3TMRI and 68Ga-PSMA PET/CT Guided Prostate Biopsy and Tumor Node Metastasis (TNM) Staging. (NCT03465579) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2018-05-23 |
| PSMA-PET Guided Radiotherapy (NCT03525288) | Centre hospitalier de l'Université de Montréal (CHUM) | 2018-05-15 |
| Focal Prostate Imaging With CLE and OCT (NCT03253458) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2018-05-11 |
| Diet and Exercise Interventions Among Men With Prostate Cancer (Prostate 8-II) (NCT03999151) | University of California, San Francisco | 2018-05-11 |
| Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer (NCT03444844) | Five Eleven Pharma, Inc. | 2018-05-10 |
| Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac (NCT04172753) | University Hospital Tuebingen | 2018-05-09 |
| Exosomal microRNA in Predicting the Aggressiveness of Prostate Cancer in Chinese Patients (NCT03911999) | Chinese University of Hong Kong | 2018-05-03 |
| The Composite Steep-pulse Treatment Apparatus Used in Prostate Cancer Ablation Therapy (NCT03838432) | Second Military Medical University | 2018-05-02 |
| Exercise for Improving Prostate Oxygenation in Prostate Tumors (Exipox) (NCT03365076) | University Hospital of North Norway | 2018-05-01 |
| Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1) (NCT03493945) | National Cancer Institute (NCI) | 2018-05-01 |
| Bcl-XL_42-CAF09b Vaccination for Patients With Prostate Cancer With Lymph Node Metastases (NCT03412786) | Herlev Hospital | 2018-05-01 |
| PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases (NCT03569241) | University Hospital, Ghent | 2018-04-27 |
| 68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks (NCT03604757) | University Hospital, Bordeaux | 2018-04-25 |
| A Randomized Trial of Early Detection of Clinically Significant Prostate Cancer (ProScreen) (NCT03423303) | Tampere University | 2018-04-23 |
| Stereotactic MRI-Guided Radiation for Localized Prostate Cancer (NCT03588819) | Sunnybrook Health Sciences Centre | 2018-04-23 |
| A Study of 18F-AlF-NOTA-Neurotensin PET/CT for Imaging Prostate Cancer (NCT03516045) | Xiangya Hospital of Central South University | 2018-04-23 |
| Efficacy and Safety Assessment of IRE of Localized Prostate Cancer. (NCT03504995) | I.M. Sechenov First Moscow State Medical University | 2018-04-19 |
| 177Lu-J591 and 177Lu-PSMA-617 Combination for mCRPC (NCT03545165) | Weill Medical College of Cornell University | 2018-04-18 |
| Physical Activity in Men Newly Diagnosed With Prostate Cancer: A Feasibility Study (NCT03331458) | Duke University | 2018-04-17 |
| The Ability of Adipose Flap Over the NVB to Improve Sexual and Urinary Function Following Radical Prostatectomy (NCT04577222) | Rabin Medical Center | 2018-04-15 |
| Early Staged Consent Before Prostate Biopsy (NCT03507725) | Memorial Sloan Kettering Cancer Center | 2018-04-11 |
| Innovative Planning and Guidance System for Prostate Focal Brachytherapy (NCT03160365) | University Hospital, Brest | 2018-04-06 |
| Prostate Cancer Detection Using the Stockholm3 Test and MR/Fusion Biopsies (NCT03377881) | Karolinska Institutet | 2018-04-04 |
| Comparison Study of PET/CT or PET/MRI Imaging to Magnetic Resonance Imaging (MRI) Alone in Men With Prostate Cancer (NCT03439033) | Weill Medical College of Cornell University | 2018-04-03 |
| Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy. (NCT03228108) | Radboud University Medical Center | 2018-04-03 |
| Perineal Versus Rectal Approach for Prostate Biopsy to Prevent Iatrogenic Infections (NCT03496142) | Institut Mutualiste Montsouris | 2018-04-01 |
| Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer (NCT03471650) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-03-29 |
| MRI Guided Focal Laser Ablation of Prostate Cancer (NCT03650595) | University Health Network, Toronto | 2018-03-29 |
| A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR) (NCT03311555) | Andrew J. Armstrong, MD | 2018-03-28 |
| CivaSheet With Radical Prostatectomy & Adjuvant External Beam Radiation (NCT03657108) | Icahn School of Medicine at Mount Sinai | 2018-03-27 |
| Penile Length Maintenance Post-Prostatectomy (NCT03500419) | Mayo Clinic | 2018-03-23 |
| Metabolic Change in Prostate Cancer Bone Metastases on 68Ga-HBED-CC-PSMA PET/CT Following Radium-223 Therapy (NCT03062254) | Sir Mortimer B. Davis - Jewish General Hospital | 2018-03-22 |
| Combination Immunotherapy in Biochemically Recurrent Prostate Cancer (NCT03315871) | National Cancer Institute (NCI) | 2018-03-20 |
| A Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive Tumors (NCT02978586) | Case Comprehensive Cancer Center | 2018-03-14 |
| Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing (NCT03511235) | Myriad Genetic Laboratories, Inc. | 2018-03-12 |
| Health Related Quality of Life and Multidimensional Evaluations of Prostate Cancer Subjects Aged ≥ 60 Years Initiating Gonadotropin-Releasing Hormone (GNRH) Agonist Therapy (NCT03516110) | Ipsen | 2018-03-09 |
| Study of TRC105 With Abiraterone and With Enzalutamide in Prostate Cancer Patients Progressing on Therapy (NCT03418324) | Cedars-Sinai Medical Center | 2018-03-05 |
| Prostatic Artery Embolization in Advanced Prostate Cancer (NCT03457805) | Dominik Abt | 2018-03-02 |
| A Phase II Study to Evaluate Axumin PET/CT for Risk Stratification for Prostate Cancer (NCT03373006) | HALO Diagnostics | 2018-02-27 |
| Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy (NCT03424850) | Washington University School of Medicine | 2018-02-27 |
| Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer (NCT03354416) | National Cancer Institute (NCI) | 2018-02-26 |
| Designing a Digital Tool to Support Healthy Lifestyle in Men With Prostate Cancer (NCT03692000) | Danish Cancer Society | 2018-02-23 |
| Therapeutic Vaccine Plus PD-1 Knockout in Prostate Cancer Treatment (NCT03525652) | The First Affiliated Hospital of Guangdong Pharmaceutical University | 2018-02-22 |
| 68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer (NCT03389451) | Michael Graham PhD, MD | 2018-02-16 |